709 results on '"D'Amato, Robert J."'
Search Results
2. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
3. Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma
4. Angiogenic responses in a 3D micro-engineered environment of primary endothelial cells and pericytes
5. PR1P ameliorates neurodegeneration through activation of VEGF signaling pathway and remodeling of the extracellular environment
6. Targeting endothelial FOXO1 protects diabetic β-cells and improves wound healing
7. Low dose amiodarone reduces tumor growth and angiogenesis
8. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes
9. Cellular mechanism of oral absorption of solidified polymer micelles
10. A novel strategy to enhance angiogenesis in vivo using the small VEGF-binding peptide PR1P
11. Renal Cell Carcinoma
12. Prostate Cancer
13. Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus
14. Cytokine Gene Therapy for Genitourinary Cancer
15. Immuno-gene Therapy for Metastatic Prostate Cancer
16. Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate Cancer
17. Therapy for Patients with Uncommon Histologic Varieties of Renal Cell Carcinoma
18. Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer
19. Phase I Trial of Everolimus Plus Sorafenib for Patients with Advanced Renal Cell Cancer
20. Thalidomide and Analogs
21. Circulating Endothelial Progenitor Cells Are Up-Regulated in a Mouse Model of Endometriosis
22. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo
23. Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment
24. A retrospective review of combination chemohormonal therapy as initial treatment for locally advanced or metastatic adenocarcinoma of the prostate
25. Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostate
26. 2-Methoxyestradiol, an Endogenous Mammalian Metabolite, Inhibits Tubulin Polymerization by Interacting at the Colchicine Site
27. Thalidomide is an Inhibitor of Angiogenesis
28. Parkinsonism-Inducing Neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the Metabolite N-methyl-4-phenylpyridine by Dopamine Neurons Explains Selective Toxicity
29. Ontogeny of the Serotonergic Projection to Rat Neocortex: Transient Expression of a Dense Innervation to Primary Sensory Areas
30. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis
31. The albino mutation of tyrosinase alters ocular angiogenic responsiveness
32. The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action
33. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
34. Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States
35. MVA–5T4-induced immune responses are an early marker of efficacy in renal cancer patients
36. Pilot Study of Rapamycin in Patients with Hormone-Refractory Prostate Cancer
37. Motexafin Gadolinium for the Treatment of Metastatic Renal Cell Carcinoma: Phase II Study Results
38. 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor-1α and Suppresses Growth of Lesions in a Mouse Model of Endometriosis
39. Clinical outcomes model in renal cell cancer patients treated with modified vaccinia Ankara plus tumor-associated antigen 5T4
40. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
41. A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma
42. Anti-angiogenic properties of microRNA-29a in preclinical ocular models.
43. Heat shock protein-peptide complex-96 (Vitespen) for the treatment of cancer
44. Angiogenic responses in a 3D micro-engineered environment of primary endothelial cells and pericytes
45. Molecular-targeted Therapy for Renal Cell Carcinoma
46. Biomarkers in Oncology and Nephrology
47. Contributors
48. Targeted Anti-Cancer Therapies for Renal Cancer
49. Interferon-α plus capecitabine and thalidomide in patients with metastatic renal cell carcinoma: A pilot study
50. Inhibition of DNA Methylation by Antisense Oligonucleotide MG98 as Cancer Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.